130 related articles for article (PubMed ID: 29934959)
21. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
[TBL] [Abstract][Full Text] [Related]
22. Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer.
López RV; Zago MA; Eluf-Neto J; Curado MP; Daudt AW; da Silva-Junior WA; Zanette DL; Levi JE; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho JF; Boffetta P; Wünsch-Filho V
Braz J Med Biol Res; 2011 Oct; 44(10):1006-12. PubMed ID: 21845339
[TBL] [Abstract][Full Text] [Related]
23. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
24. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
25. Stroke After Radiation Therapy for Head and Neck Cancer: What Is the Risk?
Arthurs E; Hanna TP; Zaza K; Peng Y; Hall SF
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):589-96. PubMed ID: 27681754
[TBL] [Abstract][Full Text] [Related]
26. Incidence and prediction of major cardiovascular complications in head and neck surgery.
Datema FR; Poldermans D; Baatenburg de Jong RJ
Head Neck; 2010 Nov; 32(11):1485-93. PubMed ID: 20146334
[TBL] [Abstract][Full Text] [Related]
27. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
Nygård M; Aagnes B; Bray F; Møller B; Mork J
Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma of the head and neck (HNSCC)--multi-modality treatment and impact on survival.
Chan GG; Tai BC; Liang S; Lim DT; Soo KC
Asian J Surg; 2002 Jan; 25(1):35-40. PubMed ID: 17585443
[TBL] [Abstract][Full Text] [Related]
29. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.
Ragin CC; Taioli E
Int J Cancer; 2007 Oct; 121(8):1813-20. PubMed ID: 17546592
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment.
Kang HS; Roh JL; Kim MJ; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2016 Jan; 142(1):295-304. PubMed ID: 26341665
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
[TBL] [Abstract][Full Text] [Related]
32. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
[TBL] [Abstract][Full Text] [Related]
34. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
35. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
36. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
[TBL] [Abstract][Full Text] [Related]
37. Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.
Gupta A; Stokes W; Eguchi M; Hararah M; Amini A; Mueller A; Morgan R; Bradley C; Raben D; McDermott J; Karam SD
Oral Oncol; 2019 Mar; 90():54-66. PubMed ID: 30846177
[TBL] [Abstract][Full Text] [Related]
38. MAGE-A1-6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes.
Noh ST; Lee HS; Lim SJ; Kim SW; Chang HK; Oh J; Jeon CH; Park JW; Lee KD
Int J Clin Oncol; 2016 Oct; 21(5):875-882. PubMed ID: 27230992
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
Ko HC; Chen S; Wieland AM; Yu M; Baschnagel AM; Hartig GK; Harari PM; Witek ME
Head Neck; 2017 Nov; 39(11):2159-2170. PubMed ID: 28737019
[TBL] [Abstract][Full Text] [Related]
40. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
